Cargando…
Management and prevention of corneal graft rejection
The management of an episode of corneal graft rejection (CGR) is primarily by corticosteroids. Immunomodulators are useful for long-term immunosuppression and in dealing with cases of high-risk (HR) corneal grafts. The classical signs of CGR following penetrating keratoplasty (PKP) include rejection...
Autores principales: | Mandal, Sohini, Maharana, Prafulla K, Kaweri, Luci, Asif, Mohamed I, Nagpal, Ritu, Sharma, Namrata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565940/ https://www.ncbi.nlm.nih.gov/pubmed/37602601 http://dx.doi.org/10.4103/IJO.IJO_228_23 |
Ejemplares similares
-
Immunopathogenesis of corneal graft rejection
por: Maharana, Prafulla Kumar, et al.
Publicado: (2023) -
Ocular manifestations in Kindler syndrome
por: Maharana, Prafulla K, et al.
Publicado: (2022) -
A review of techniques and outcomes of endothelial keratoplasty in congenital hereditary endothelial dystrophy
por: Mandal, Sohini, et al.
Publicado: (2022) -
Commentary: Publication trend of COVID-19 and non-COVID-19 articles in the Indian Journal of Ophthalmology during COVID-19 pandemic
por: Nagpal, Ritu, et al.
Publicado: (2021) -
Commentary: Dye-based identification of the orientation of tissue for Descemet stripping automated endothelial keratoplasty: A laboratory-based study
por: Nagpal, Ritu, et al.
Publicado: (2021)